Welcome to LookChem.com Sign In|Join Free
  • or
N-(9-((2R,3R,4R,5S)-4-amino-3-((tert-butyldimethylsilyl)oxy)-5-(tert-butyldimethylsilyloxymethyl)tetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

420122-78-7

Post Buying Request

420122-78-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

420122-78-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 420122-78-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,2,0,1,2 and 2 respectively; the second part has 2 digits, 7 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 420122-78:
(8*4)+(7*2)+(6*0)+(5*1)+(4*2)+(3*2)+(2*7)+(1*8)=87
87 % 10 = 7
So 420122-78-7 is a valid CAS Registry Number.

420122-78-7Relevant academic research and scientific papers

P(III) vs P(V): A P(V) Reagent for Thiophosphoramidate Linkages and Application to an Asymmetric Synthesis of a Cyclic Dinucleotide STING Agonist

Ayers, Sloan,Cohen, Ben,Eastgate, Martin D.,Freitag, Adam,Fu, Weiqing,Guo, Siwei,Hang, Chao,He, Brian L.,Hritzko, Ben,Park, Hyunsoo,Paulson, James,Purdum, Geoffrey E.,Rogers, Amanda,Schmidt, Michael A.,Sezen-Edmonds, Melda,Shackman, Jonathan G.,Tai, Hua Chia,Treitler, Daniel S.,Wang, Qinggang,Yu, Miao,Yuan, Changxia,Zheng, Bin,Zhu, Guanghui,Zhu, Jason,Zhu, Ye

, (2021)

A highly stereoselective synthesis of a cyclic dinucleotide (CDN) STING agonist containing two chiral thiophosphoramidate linkages is described. These rare yet key functional groups were, for the first time, installed efficiently and with high diastereoselectivity using a specially designed P(V) reagent. By utilizing this strategy, the CDN was prepared in greater than 16-fold higher yield than the prior P(III) approach, with fewer hazardous reagents and chromatographic purifications.

PROCESS FOR THE PREPARATION OF A CYCLIC DINUCLEOTIDE

-

Page/Page column 12-13, (2020/07/05)

The invention generally relates to an improved processes for the preparation of a cyclic dinucleotide which is useful as a STING agonist of the following formula (I), involving the use of compounds A and B.

SYNTHESIS OF 1,2,5-TRI-0-BENZ0YL-3-DIBENZYLAMIN0-3-DE0XYRIB0SE AS INTERMEDIATE FOR PRODUCING 3'-AMINO-3'-DEOXYADENOSINE AND 3'-AMINO-3'-DEOXYGUANOSINE AND THE PROTECTED DERIVATIVES THEREOF

-

, (2020/08/22)

The invention generally relates to improved processes for the preparation of intermediates of a cyclic dinucleotide which is useful as a STING agonist.

Synthesis and biological evaluation of non-isomerizable analogues of Ala-tRNAAla

Mellal, Denia,Fonvielle, Matthieu,Santarem, Marco,Chemama, Maryline,Schneider, Yoann,Iannazzo, Laura,Braud, Emmanuelle,Arthur, Michel,Etheve-Quelquejeu, Mélanie

, p. 6161 - 6169 (2013/09/12)

Aminoacyl-tRNAs serve as amino acid donors in many reactions in addition to protein synthesis by the ribosome, including synthesis of the peptidoglycan network in the cell wall of bacterial pathogens. Synthesis of analogs of aminoacylated tRNAs is critica

Synthesis of ribonucleic guanidine: Replacement of the negative phosphodiester linkages of RNA with positive guanidinium linkages

Kojima, Naoshi,Szabo, Istvan E,Bruice, Thomas C

, p. 867 - 879 (2007/10/03)

Replacement of the negatively charged phosphodiester linkages of RNA with positively charged guanidinium linkages provides the polycationic ribonucleic guanidine (RNG). RNG is designed to bind strongly to target DNA/RNA through the specific interactions o

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 420122-78-7